Teva Jumps as New Drugs Bolster Outlook: Israel Overnight

Teva Pharmaceutical Industries extended its best start to a year since 2010 as exclusive rights to sell two medications boosted prospects U.S. sales for the world’s largest maker of generic drugs will recover in 2012.
Bloomberg